XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net loss $ (165,240) $ (879,166) $ (376,250)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 233,940 246,561 125,292
Share-based compensation 426,679 386,009 357,965
Unrealized loss on investments 1,506 203,483 14,611
Asset write-down and other charges 0 305,351 0
Amortization of deferred and prepaid sales commission costs 138,134 115,184 74,165
Amortization of debt discount and issuance costs 4,566 4,468 64,063
Loss (gain) on early extinguishment of debt (53,400) 0 1,736
Repayment of convertible notes attributable to debt discount 0 0 (10,131)
Reduction of operating lease right-of-use assets 20,469 19,907 18,025
Provision for bad debt 6,852 9,367 8,132
Other 1,486 4,327 809
Changes in assets and liabilities:      
Accounts receivable (57,819) (87,843) (64,940)
Deferred and prepaid sales commission costs (156,734) (235,869) (178,358)
Prepaid expenses and other assets 14,492 3,812 9,111
Accounts payable (21,213) (6,166) 17,852
Accrued and other liabilities 9,101 89,473 74,517
Deferred revenue 17,681 33,275 34,227
Operating lease liabilities (20,838) (20,868) (18,675)
Net cash provided by operating activities 399,662 191,305 152,151
Cash flows from investing activities      
Purchases of property and equipment (23,513) (32,713) (28,959)
Capitalized internal-use software (52,227) (53,730) (43,692)
Cash paid for business combination, net of cash acquired (14,709) 0 0
Purchases of intangible assets and long-term investments 0 (3,990) (324,178)
Proceeds from sale of marketable equity investments 0 3,223 0
Net cash used in investing activities (90,449) (87,210) (396,829)
Cash flows from financing activities      
Proceeds from issuance of stock in connection with stock plans 16,687 15,855 36,721
Payments for taxes related to net share settlement of equity awards (9,062) (7,598) (21,549)
Payments for repurchase of common stock (311,088) (99,793) 0
Proceeds from issuance of long-term debt, net of issuance costs 785,749 0 0
Proceeds from series A convertible preferred stock, net of issuance costs 0 0 199,449
Payments for the repurchase of convertible notes (820,960) 0 (333,632)
Repayments of principal on term loan (10,000) 0 0
Repayment of financing obligations (5,777) (4,815) (4,160)
Payment for contingent consideration (3,567) (1,867) (3,880)
Net cash used in financing activities (358,018) (98,218) (127,051)
Effect of exchange rate changes 1,016 (3,055) (962)
Net increase (decrease) in cash, cash equivalents, and restricted cash (47,789) 2,822 (372,691)
Cash, cash equivalents, and restricted cash      
Beginning of year 269,984 267,162 639,853
End of year 222,195 269,984 267,162
Supplemental disclosure of cash flow data:      
Cash paid for interest, net of interest rate swap 16,629 347 309
Cash paid for income taxes, net of refunds 10,940 3,726 1,388
Non-cash investing and financing activities      
Common stock issued in connection with strategic partnership arrangement 55,014 0 0
Common stock issued for acquisition of intangible assets 0 0 302,600
Contingent consideration 7,461 0 50,000
Equipment and capitalized internal-use software purchased and unpaid at period end 3,953 6,808 7,343
Acquisition of intangibles 3,629 0 0
Equipment acquired under financing obligations $ 2,997 $ 0 $ 6,898